2021
DOI: 10.1016/j.ijporl.2021.110817
|View full text |Cite
|
Sign up to set email alerts
|

Whole exome sequencing of six Chinese families with hereditary non-syndromic hearing loss

Abstract: Background:Hereditary non-syndromic hearing loss (NSHL) has a high genetic heterogeneity with >152 genes identi ed as associated molecular causes. The present study aimed to detect the possible damaging variants of the deaf probands from six unrelated Chinese families. Methods:After excluding the mutations in the most common genes, GJB2 and SLC26A4, 12 probands with prelingual deafness and autosomal recessive inheritance were evaluated by whole-exome sequencing (WES). All the candidate variants were veri ed by… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

1
4
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
4
1

Relationship

0
5

Authors

Journals

citations
Cited by 7 publications
(5 citation statements)
references
References 28 publications
1
4
0
Order By: Relevance
“…(Gln74*) truncating founder variant that has a minor allele frequency of 0.558% in the East Asian subpopulation. This variant was also recently reported in the homozygous state in five individuals of Chinese descent (Li et al, 2023).…”
Section: Discussionsupporting
confidence: 72%
See 3 more Smart Citations
“…(Gln74*) truncating founder variant that has a minor allele frequency of 0.558% in the East Asian subpopulation. This variant was also recently reported in the homozygous state in five individuals of Chinese descent (Li et al, 2023).…”
Section: Discussionsupporting
confidence: 72%
“…An additional rare c.52C>T,p. (Leu18Phe) missense variant was recently reported in one patient (patient 34) who also carried the c.220C>T,(p.Gln74*) truncating variant (Li et al, 2023). The c.52C>T,p.…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…The rapid development of next‐generation sequencing (NGS) makes it possible to analyse all genes in one test. Whole‐exome sequencing (WES), a platform of NGS, offers powerful applications for diagnosis as well as for identifying rare variants or new causative genes (Liang et al., 2021 ).…”
Section: Introductionmentioning
confidence: 99%